IT

BioEnterprise's Midwest Health Care Venture Investment Report showed a total 47 companies raising a combined $155.6 million during the first quarter of 2009, compared with 14 companies winning $133.5 million in the year-ago period.

Some of NIH's and NHGRI's challenge grants will give priorities to ethical issues that confront genomics, pharmacogenomics, and biomedicine.

Paired Ends

Premium

Helaman Escobar, John Keilty, Lutz Kirchrath

The Northwest Association for Biomedical Research has received a three year, $1.3 million grant from the National Science Foundation to support its education outreach programs.

Looking to support local industry and nurture Ireland's economic recovery, University College Dublin and Trinity College Dublin will combine their existing programs in tech transfer, enterprise development, industry relations, and post-graduate entrepreneurial education, largely in the area of life sciences.

The company will use the Expressionist and Phylosopher software in its search for transplantation and autoimmune biomarkers.

BioRegion Real Estate

Premium

Pfizer La Jolla Incubator, Chromocell, NJEDA Biotechnology Development Center, Wockhardt USA LLC, Acorda Therapeutics, Eastman Business Park, Qatar Science & Technology Park, and more…

People in the News

Kevin Conroy has been named the new president and CEO of Exact Sciences, while Don St. Pierre is serving as the acting director of FDA's Office of In Vitro Diagnostics, plus more.

The study suggests it is "unlikely" that patents protecting biomedical inventions "will ever be licensed" if they have remained unlicensed for more than eight years since their priority patent application was filed.

Pages

Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.

Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.

In Science this week: research regulation and reporting requirement reform, and more.

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.